Pharmaceutical Technology, December 3rd, 2006
Micron Technologies offers contract particle-size reduction and analytical services exclusively for the pharmaceutical industry. With two modern, directly compatible facilities in the United Kingdom and the United States, Micron Technologies provides a truly global capability. Primary capabilities involve micronization in addition to other particle-reduction techniques.
Processing takes place in segregated, independent processing suites in a climate-controlled environment. Optimum operator protection in "airsuits" allows for processing of potent compounds and cytotoxics (case-by-case). Product-contact air is Class 1000 and has a dewpoint of 240 °C. Milling under nitrogen also is available. Micron has the capacity to process gram-to-ton quantities with high yields.
Micron's analytical laboratory provides extensive material characterization testing, including particle-size analysis (wet and dry), DSC, specific surface area, X-ray diffraction, and method development and validation. Additional analytical capabilities include stability studies, HPLC, FT IR, Karl Fischer, and video microscopy.
Micron's independent quality-assurance group ensures a high level of compliance and is responsible for all documentation creation and review, internal audits, external audits, training, and release of batches.
The company's 100% cleaning verification program also is managed and maintained by the QA group.
Along with sister company Colorcon, Micron's goal is to be the benchmark in service and products for the pharmaceutical industry. Facilities are FDA-, MCA-, and EMEA-inspected with an average of four client audits per month.
Micron Technologies, Inc.
435 Creamery Way
Exton, PA 19341
TELEPHONE
US: 610.425.5100
UK: 144 1322 425200
FAX
US: 610.425.5104
UK: 144 1322 425201
E-MAIL
bhausner@microntechnologies.com
WEB SITE
www.microntech.com|~
DATE FOUNDED
1996
